Zealand Pharma Announces Financial Results for the First Nine Months of 2026
Company announcement — No. 56 / 2026Zealand Pharma Announces Financial Results for the First Nine Months of 2026Advancing at pace towards Metabolic Frontier 2030: petrelintide in Phase 3, survodutide moving towards regulatory filings, positive CHMP opinion for Zeydovio(TM), and new modalities for…